Delivery Order SPE2DB22D2007-SPE2DB24FH7ZV
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,299.44 firm fixed-price delivery order is for the supply of Ketorolac 30 mg/ml vials, a pain management medication. The contract has a completion date of November 7, 2024 and was awarded on November 6, 2024. This award is a part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of Ketorolac 30 mg/ml vials to the Defense Logistics Agency (DLA). The $25,903.16 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of December 8, 2023 and was awarded on December 7, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,163.76, is a Firm Fixed Price Delivery Order for the supply of Ketorolac 30 mg/ml vials. The contract has an ultimate completion date of April 9, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,451.88 firm fixed-price delivery order is for the supply of Ketorolac 30 mg/ml vials, a pharmaceutical product. The contract has an ultimate completion date of September 25, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued up...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,631.52 firm-fixed-price delivery order contract covers the delivery of Ketorolac 30 mg/ml vial, a pain medication, through January 2, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Ketorolac 30mg/ml 25s, a pain medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,029.16, is a firm fixed-price delivery order contract with a completion date of December 12, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award, valued at $1,172.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Ketorolac 60 mg/2 ml vials, a pharmaceutical product, with a performance period extending to March 15, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order placed by the Defense Logistics Agency (DLA) for the pharmaceutical product Ketorolac 30 mg/ml vial. The $1,539.60 Firm Fixed Price contract has a completion date of May 6, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,453.20 firm fixed-price delivery order is for the supply of 30 mg/mL ketorolac vials, a medication used for pain management. The contract has a completion date of December 8, 2023 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The $3,600.88 firm fixed-price delivery order is for the supply of KETOROLAC 30 MG/ML VIALML, a pharmaceutical product. The contract has an ultimate completion date of July 18, 2025 and was competitively awarded with no set-aside designation. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FH7ZVDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,629.70 firm fixed-price delivery order is for the supply of 4563142798 - Ketorolac 30 mg/ml vial, a pain management medication, with a completion date of December 20, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 12/19/23 |